US Patent 12077790 Optimized binuclease fusions and methods
Patent 12077790 was granted and assigned to Resolve Therapeutics on September, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12077790 Optimized binuclease fusions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.